Pancreatic NETs frequently exhibit changes in genes such as MEN1, DAXX, ATRX, TSC1, TSC2, CDKN1A, and CDKN1B, along with alterations in CDKN2A and SETD2 in metastatic lesions. This evidence concerns the gene ATRX and pancreatic neuroendocrine tumor.